Key Highlights

● United Maritime declared its 15th consecutive quarterly Dividend of $0.10 per share for its six-vessel dry-bulk fleet.

● Cryoport posted second-quarter Revenue of $49.0 million and reached its first quarter of positive adjusted EBITDA.

● Imperial Petroleum reported $34.8 million in Net Income on a debt-free Balance Sheet with rising liquidity.

● Seanergy Maritime's fleet-wide time charter equivalent rate jumped 63% year over year to $32,355 per day.

Four Greece-based shipping companies and one cold-chain logistics provider for life sciences sit side by side on the Nasdaq this September, each reporting second-quarter 2026 results shaped by very different forces, from Capesize freight rates to clinical-trial demand.

Five Very Different Businesses, One Nasdaq Corner

The transportation and logistics corner of the Nasdaq rarely draws much attention, but a mixed basket of names such as United Maritime Corporation (NASDAQ: USEA), Cryoport, Inc. (NASDAQ: CYRX), Imperial Petroleum Inc. (NASDAQ: IMPP), Seanergy Maritime Holdings Corp. (NASDAQ: SHIP) and Globus Maritime Limited (NASDAQ: GLBS) shows how differently that theme can play out. Four of the five are Greece-based ocean shippers whose results move with dry-bulk and tanker charter rates, while the fifth, Cryoport, is a temperature-controlled logistics provider serving the cell and gene therapy industry. Grouping them together is a way of viewing the sector rather than a claim that they compete with one another.

Each company built its results around the quarter ended 30 June 2026, releasing figures on its own schedule between late July and mid-September. What follows works through those second-quarter and first-half numbers, along with the fleet and balance-sheet detail that shows where each Business stands heading into the back half of the year.

The Freight Cycle and Cold-Chain Backdrop

The backdrop for the four shipping companies is a dry-bulk market that stayed firm but choppy through early September. On 11 September 2026, the Baltic Dry index stood at 3,507, with the Capesize sub-index at 6,080 and average Capesize daily Earnings around $55,139, while the Panamax index sat at 2,407 with daily income near $21,662. Market commentary at the time described a modest correction after gains earlier in the month, with Pacific Volatility and prompt Panamax oversupply weighing on sentiment.

That split matters for the group below. Capesize-exposed operators have had a stronger 2026 than owners of smaller vessels, a pattern that shows up directly in the time charter equivalent rates each company reported. Cryoport sits outside that cycle entirely, insulated from spot freight rates and instead driven by clinical-trial activity and biopharma demand, a reminder that logistics on the Nasdaq spans very different economic engines.

United Maritime Corporation (NASDAQ:USEA): A Small Fleet With a Long Dividend Streak

United Maritime, a Greece-based dry-bulk owner spun off from Seanergy Maritime in 2022, reported second-quarter 2026 net revenue of $10.0 million and net income of $1.2 million, with first-half net revenue of $17.9 million and net income of $1.0 million, according to its 30 July 2026 results release. The company operates six dry-bulk vessels totaling 666,260 dwt, two Capesize, one Kamsarmax and three Panamax, and disclosed a pending sale of the M/V Exelixsea that would leave five vessels and 589,899 dwt.

Its reported second-quarter time charter equivalent rate was $18,654 per day, with a first-half TCE of $17,202, up 35% year over year, and third-quarter guidance of roughly $20,418 per day. United declared its 15th consecutive quarterly dividend of $0.10 per share, payable 9 October 2026.

With about 9.2 million weighted-average shares outstanding, United Maritime is a genuine micro-cap where a single vessel sale materially changes capacity. The dividend streak signals an intent to keep returning cash, though payouts remain tied to charter rates holding up, and the company's Seanergy lineage is worth noting given that family's own history of reverse stock splits.

Cryoport, Inc. (NASDAQ:CYRX): Cold-Chain Logistics for the Cell and Gene Therapy Era

Cryoport is a temperature-controlled logistics and support company for life sciences, and it stands apart from the four shipping companies in this group. It reported second-quarter 2026 total revenue of $49.0 million, up 8% year over year, split between Life Sciences Services of $28.0 million, up 15%, and Life Sciences Products of $21.0 million, roughly flat, according to its 6 August 2026 results release. The company posted a net loss of $8.3 million but reached positive adjusted EBITDA of $0.4 million, a milestone it highlighted, while holding $396.7 million in cash, equivalents and short-term investments.

Within services, BioLogistics Solutions revenue rose 13% to $22.4 million and BioStorage and BioServices grew 25% to $5.6 million. The company said it supported 779 Clinical Trials and 22 commercially approved cell and gene therapies. First-half revenue reached $96.8 million, up 12%, with a net loss of $18.8 million.

The underlying story is operating leverage: services growth alongside the first positive adjusted-EBITDA quarter suggests the cost base is beginning to scale. Sustained profitability is not guaranteed while GAAP losses persist, and revenue still depends on biopharma trial funding and commercial therapy launches, both of which can slow.

Imperial Petroleum Inc. (NASDAQ:IMPP): Tankers, Dry Bulk and a Debt-Free Balance Sheet

Imperial Petroleum, a Greece-based owner of product tankers and dry-bulk carriers, reported its second-best quarterly figures on record: second-quarter 2026 revenue of $87.1 million, net income of $34.8 million, Basic Earnings Per Share of $0.75 and EBITDA of $41.2 million, according to its 10 September 2026 results release. First-half revenue reached $148.8 million with net income of $62.8 million.

Its fleet stood at 21 vessels totaling 1,197,000 dwt as of 10 September 2026, spanning seven MR product tankers, one Suezmax and a mix of Handysize, Supramax, Kamsarmax and Post-Panamax dry-bulk carriers, with further additions announced. The company reported zero Debt and Liquidity of $245.2 million at 30 June 2026, which management said had since risen to roughly $260 million.

Imperial's share count carries some history worth noting: a 1-for-15 Reverse Stock Split effective 28 April 2023 cut shares outstanding from about 248 million to roughly 16.5 million to meet Nasdaq's $1.00 minimum bid price rule. That episode sits firmly in the past; the balance sheet today is debt-free with a diversified tanker and bulk mix, even though product-tanker earnings remain cyclical.

Seanergy Maritime Holdings Corp. (NASDAQ:SHIP): The Capesize Pure-Play Riding Strong Rates

Seanergy Maritime, a Greece-based Capesize specialist, delivered record-flavored numbers: second-quarter 2026 net revenue of $55.7 million and net income of $26.2 million, with earnings per share of $1.21 and $1.32 on an adjusted basis, and first-half net revenue of $97.8 million and net income of $35.9 million, according to its second-quarter results release. Its fleet-wide time charter equivalent rate was $32,355 per day in the second quarter, up 63% year over year, with third-quarter guidance around $31,000.

The company operates 19 vessels, two Newcastlemax and 17 Capesize, and is executing a roughly $591 million fleet renewal program aimed at growing to 26 vessels, funded alongside a declared $0.35 per-share dividend, its 19th consecutive payout. It reported $59.5 million in cash, $294.9 million in long-term debt and $313.1 million in Equity at 30 June 2026.

Seanergy is the clearest beneficiary of the strong Capesize market underpinning September's freight readings, and its scale dwarfs United Maritime and Globus Maritime on revenue. The renewal program adds future capacity but also debt and delivery risk stretching into 2027-2029, and the company's own history of multiple reverse stock splits is a reminder of how volatile its share count has been.

Globus Maritime Limited (NASDAQ:GLBS): Smaller Vessels, Improving Margins

Globus Maritime, a Greece-based dry-bulk owner, reported second-quarter 2026 revenue of $14.6 million and net income of $4.0 million, with basic earnings per share of $0.19, swinging from a year-earlier loss, and adjusted EBITDA of $9.1 million, according to its 7 August 2026 results release. First-half revenue was $26.9 million with net income of $5.1 million.

Its fleet is nine vessels totaling 680,622 dwt, six Kamsarmax and three Ultramax, with a weighted-average age of 8.7 years and 99.5% utilization during the quarter. The reported second-quarter time charter equivalent rate was $19,686 per day, up sharply from $11,462 a year earlier, against daily operating expenses of $5,787. The company held $31.8 million in cash and $105.4 million in total debt, with equity of $181.1 million and about 21.6 million weighted-average shares; no dividend was disclosed.

Globus carries a long history of reverse stock splits across prior years, a recurring feature of its capital structure. Its mid-size fleet is more exposed to the softer Panamax and Kamsarmax segment than to Capesize strength, and while the wide gap between its time charter equivalent rate and operating expenses supports profitability if rates hold, the smaller-vessel oversupply noted in September commentary is a headwind worth watching.

What Investors Should Watch

The near-term swing Factor for United Maritime, Imperial Petroleum, Seanergy Maritime and Globus Maritime is the freight cycle, and the underlying sub-indices are pulling in different directions. Capesize strength has been the standout of 2026, favoring Seanergy's fleet and United Maritime's larger vessels, while Panamax and Kamsarmax oversupply pressures Globus Maritime and part of Imperial Petroleum's book. Third-quarter TCE guidance, where offered, gives a forward read but remains an estimate rather than a promise.

Capital structure is the second item worth tracking. Reverse stock splits at Imperial Petroleum, the Seanergy family and Globus Maritime mean per-share history is not continuous for any of them, and headline share prices can mislead without adjusting for those actions. Dividend durability at United Maritime and Seanergy Maritime depends on Cash Flow that tracks volatile freight rates.

For Cryoport, the signals to watch are different: clinical-trial counts, commercial therapy approvals, services Margin and the path from positive adjusted EBITDA toward GAAP profitability.

Different Cargo, Same Ticker Tape

Strip away the ticker symbols and the group splits cleanly into two stories. United Maritime, Imperial Petroleum, Seanergy Maritime and Globus Maritime are all reading from the same dry-bulk freight cycle, just from different points on the vessel-size spectrum, while Cryoport answers to clinical-trial counts and biopharma budgets instead of the Baltic Dry Index.

On the numbers reported for the second quarter, Seanergy and Imperial Petroleum stand out on scale and profitability, United Maritime keeps its small-cap dividend streak intact, Globus Maritime has turned the corner into profitability on stronger rates, and Cryoport is edging toward sustainable margins after its first quarter of positive adjusted EBITDA.

Reverse-split histories at three of the four shipping companies mean per-share comparisons over time need care, and every result in this group still depends on freight rates or biopharma Demand that can shift from one quarter to the next.